NCT06995625View on ClinicalTrials.gov

The STem Cell-derived Extracellular Vesicle Therapy In Acute Ischemic Stroke (STEVIA)

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2027

Conditions
Acute Ischemic Stroke AIS
Interventions
DRUG

SNE-101

Experimental: Cohort 1 - SNE-101 4.8 × 10e10 particles (n=3 to 6) Experimental: Cohort 2 - SNE-101 9.6 × 10e10 particles (n=3 to 6) Experimental: Cohort 3 - SNE-101 19.2 × 10e10 particles (n=3 to 6)

Trial Locations (3)

16499

Ajou University Hospital, Suwon

06351

Samsung Medical Center, Seoul

07804

Ewha Womans University Seoul Hospital, Seoul

All Listed Sponsors
lead

S&Ebio Co. Ltd.

INDUSTRY